文献速递中药与中成药合理使用中医内科

中药成分与制剂在疾病治疗中类组蛋白去乙酰化酶抑制剂作用的研究进展

Research on the progress of Traditional Chinese medicine components and preparations on histone deacetylase inhibitors - Like effects in the course of disease treatment.
PubMed 文献 · J Ethnopharmacol · 2022-07-06

本文综述组蛋白去乙酰化酶(HDAC)的作用机制及中药与HDAC的表观遗传学关联,基于PubMed、CNKI等数据库截至2022年3月的文献,总结天然药物类HDACi抑制效应与临床应用。大量研究证明多种中药及其化学成分可抑制HDAC活性,具有高选择性,作用于不同HDAC亚型,在癌症、心脑血管疾病、骨科疾病、皮肤病等中发挥治疗作用。

要点

  • 多种中药成分及复方可抑制HDAC活性,具亚型选择性。
  • 类HDACi作用在癌症、心脑血管、骨科及皮肤病中显示疗效。
  • 为开发新型HDACi及挖掘中药活性成分提供思路。

核心结论

  • 多种中药及其化学成分具有抑制HDAC活性的类HDACi效应,并具高选择性及亚型差异。
  • 该类作用在癌症、心脑血管疾病、骨科疾病和皮肤病等中显示一定治疗作用。
  • 综述有助于挖掘中药活性成分并为新型HDACi开发提供思路。

研究设计与样本

  • 综述检索PubMed、CNKI、万方、Elsevier、Web of Science及中国生物医学文献数据库截至2022年3月前发表的文献。
  • 检索词包括「HDAC」或「HDACi」以及「herb」或「herbal ingredient」。

主要发现

  • 大量研究证明多种中药及其化学成分可抑制HDAC活性。
  • 该类抑制具有高选择性,作用于不同HDAC亚型。
  • 通过抑制HDAC过程在癌症、心脑血管疾病、骨科疾病、皮肤病等中发挥治疗作用。

关键数值与推荐

  • 传统HDAC抑制剂在疾病治疗中可能出现强免疫抑制和耐药等副作用,并可能导致心、肝、肾损伤。
  • 中药被认为疗效好且安全性好,中药复方及活性成分可有效抑制HDAC表达。

临床怎么用

  • 可将具有类HDACi效应的中药成分作为挖掘活性成分及开发新型HDACi的思路来源。
  • 在癌症、心脑血管疾病、骨科疾病及皮肤病治疗中关注中药的HDAC抑制相关药理作用。

局限性

  • 本文为综述,未报告原始研究的具体样本量、效应量或统计学阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: During the treatment of diseases, histone deacetylases (HDAC) may have side effects such as strong immune inhibition and drug resistance, which may lead to damage of heart, liver and kidney. Traditional Chinese medicine (TCM) is a valuable and unique resource in China, which has good efficacy and safety. At present, it has been found that Chinese herbal compounds and active ingredients can effectively inhibit the expression of HDAC. Moreover, pharmacological studies have shown that these TCMs have shown therapeutic effects in the treatment of cancer, cardiovascular and cerebrovascular diseases, orthopedic diseases and skin diseases. AIM OF THE REVIEW: This article reviews the mechanism of action of HDAC, and introduces the epigenetic correlation between TCM and HDAC. We expounded the histone deacetylase inhibitor (HDACi)-like inhibitory effect and clinical application of natural drugs, and summarized the research progress of TCM on HDAC in recent years. MATERIALS AND METHODS: We collected relevant information published before March 2022 by searching the literature in various online databases such as PubMed, CNKI, Wanfang Database, Elsevier, Web of Science and China Biomedical Database. Search terms include "HDAC" or "HDACi", as well as "herb" or "herbal ingredient". RESULTS: A large number of studies have proved that many TCMs and their chemical components have the effect of inhibiting HDAC activity, which is highly selective, acts on different HDAC subtypes, and plays a certain therapeutic effect in cancer, cardiovascular and cerebrovascular diseases, orthopedic diseases, skin diseases and other diseases by inhibiting the process of HDAC. DISCUSSION AND CONCLUSIONS: The review of this paper is helpful to understand and excavate the active components of TCM, further explore the role of plant drugs with HDACi-like effect in diseases, and provide ideas for the development of new HDACi.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wei Y, Guo Y, Lv S, et al. Research on the progress of Traditional Chinese medicine components and preparations on histone deacetylase inhibitors - Like effects in the course of disease treatment. J Ethnopharmacol. 2022. PMID: 35809757. doi:10.1016/j.jep.2022.115521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。